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Stroke Survivors Who Score Below Threshold on Standard
Depression Measures May Still Have Negative Cognitions
of Concern
Maree L. Hackett, PhD; Kate M. Hill, PhD; Jenny Hewison, PhD; Craig S. Anderson, PhD;
Allan O. House, DM; on behalf of the Auckland Regional Community Stroke (ARCOS) Study and the
Stroke Outcomes Study (SOS2) Group
Background and Purpose—There has been an increase in screening for depression in the physically ill. We explored
whether important negative cognitions may be missed by conventional approaches to screening for depression in 2
independently conducted stroke studies with similar methods.
Methods—The Auckland Regional Community Stroke (ARCOS) study was a prospective, population-based stroke
incidence study conducted in Auckland, New Zealand, for 12 months in 2002 to 2003. The Stroke Outcomes Study was
a prospective, hospital cohort study conducted in Leeds and Bradford, United Kingdom, for 33 months in 2002 to 2005.
Symptoms of abnormal mood were assessed at 6 months in ARCOS with a single simple question, “Do you often feel
sad and depressed?” and the 28-item General Health Questionnaire administered as part of a structured interview and
in the Stroke Outcomes Study with the 28-item General Health Questionnaire and a single question about depressed
mood taken from the Present State Examination.
Results—Mood data were available at 6 months from 770 ARCOS and 492 Stroke Outcomes Study participants. A
significant proportion (up to 28%) of people who did not meet study criteria for depression reported important negative
cognitions such as hopelessness, worthlessness, or suicidality. People who were older, dependent in activities of daily
living, or not partnered were more likely to report negative cognitions.
Conclusions—Important negative cognitions, including suicidal thoughts, may be missed when people are screened for
depression after stroke. Screening alone is not an adequate substitute for a sensitive exploration of the psychological
impact of stroke on the survivor. (Stroke. 2010;41:478-481.)
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Clinicians and researchers are encouraged to screen todetect the substantial proportion of people1 who will
experience depression at some point after stroke. For exam-
ple, the National Stroke Sentinel Audit2 monitors rates of
screening for depression during admission after stroke. How-
ever, depression is a complex condition that can be concep-
tualized in different ways, which in turn, govern how it is
recognized, diagnosed, and managed.
Most commonly, depression is considered a syndrome. A
clinical diagnosis can only be made after a particular constel-
lation of signs and symptoms has been elicited through a
semistructured psychiatric interview. For a DSM-IV diagno-
sis,3 an individual must have experienced 1 of the “core
symptoms” of “depressed mood” or “a loss of interest or
pleasure” nearly every day, most of the day, in a 2-week
period. In addition, the same individual must experience at
least 4 additional symptoms of depression, such as changes in
weight or sleep or feeling restless, slowed down, fatigued, or
worthless. However, if there is no “depressed mood” or “loss
of interest or pleasure,” a diagnosis of depression will not be
achieved regardless of how many symptoms are endorsed.
Depression can also be considered an accumulation of
depressive symptoms, none of which is privileged in the way
that they are in the syndromal approach. These symptoms can
be grouped into 4 broad categories. The first consists of
affective symptoms such as depression, anxiety, irritability,
and apathy, with the second category including behavioral
symptoms such as tearfulness, reassurance seeking, inertia,
and social withdrawal. These symptoms are listed in most
structured questionnaires such as the Centre for Epidemio-
logical Studies Depression Scale4 or the Geriatric Depression
Scale.5 The third category includes somatic symptoms such as
insomnia, pains, tension, and weight loss, which have been
deliberately removed from some structured questionnaires
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(eg, Hospital Anxiety and Depression Rating Scale6) because
of a claim that these are also symptoms of physical illness that
may then be misattributed to symptoms of depression. The
last category consists of important negative cognitive symp-
toms such as hopelessness, helplessness, and suicidal
thoughts. These symptoms are also listed in most structured
questionnaires, (eg, the 28-item General Health Question-
naire (GHQ-28)7 and the Beck Depression Inventory,8) but
not all (eg, the Hospital Anxiety and Depression Rating
Scale).6 The number of symptoms endorsed is counted, and
scores above a measure-specific threshold are said to indicate
a likely case of depression.
Finally, depression may also be conceptualized as a group
of clinically important negative cognitions such as worthless-
ness or hopelessness that may be present without the tradi-
tional “core symptoms” of depressed mood or loss of interest
or pleasure, although they often coexist with somatic symp-
toms. This presentation of so-called depression without sad-
ness9 is thought to be more common in the elderly. Although
more attention has been given to depression as a risk for
mortality in the elderly,10–12 there is evidence that specific
negative cognitions may be relevant, independent of any
associated depressive diagnosis, for mortality9,13,14 and sub-
sequent physical and mental morbidity.13,15,16
Screening for depression has been largely oriented toward
measuring depressive symptom burden in its own right or as
a means of identifying people likely to meet syndrome-based
diagnostic criteria. Recently a variety of short screening
tools17–19 has been developed, the briefest of which involve
just 1 or 2 questions that ask respondents directly about the
experience of depression. For example, the National Institute
for Health and Clinical Excellence in the United Kingdom20
recommends that patients seen in primary care are asked 2
screening questions: “During the last month, have you been
feeling down, depressed, or hopeless?” and “During the last
month, have you often been bothered by having little interest or
pleasure in doing things?” Not all depression screening tools
contain negative cognitions for endorsement or only include (as
in the Patient Health Questionnaire 2-item21) reference to 1 such
symptom as part of a composite question.6,17–19
There has been relatively little exploration of which mood-
related symptoms are missed when we screen for depression
after stroke. We were especially interested in negative cognitions
in physical illness, and we therefore examined the relation
between these negative cognitions and responses to a single
question about depression and to a standardized validated
questionnaire in 2 independently conducted (with similar meth-
ods) epidemiologic stroke cohorts. Our question was whether
using these approaches to identifying depression might lead to
neglect of potentially-important negative cognitions in patients
who would not meet traditional criteria for a depression diagnosis.
Methods
The Auckland Regional COmmunity Stroke (ARCOS) study has
been described elsewhere.22 In brief, ARCOS used a prospective,
population-based register to ascertain all cases of acute new or
recurrent stroke that occurred among adults in the usually resident
population of Auckland during a 12-month period from 2002 to
2003. Each participant was interviewed as soon as possible after stroke.
All survivors were reinterviewed at 6 months when depressive symp-
toms were assessed with the Yale question, “Do you often feel sad or
depressed?”23 and symptoms of abnormal mood were assessed in
cognitively competent participants (those scoring7 on the Hodkinson
Mental Test24) with the GHQ-28 (standard 0, 0, 1, 1 scoring).7
The Stroke Outcomes Study (SOS2) was a prospective, observa-
tional cohort study of the impact of depressive symptoms on
outcomes for stroke patients. Patients from 2 large hospitals were
recruited after new or recurrent acute stroke, from Trusts in Leeds
and Bradford in the United Kingdom, between July 2002 and March
2005.25 The patients were screened with the Mini-Mental State
Examination26 and interviewed within 2 to 6 weeks (baseline
assessment) after their index stroke episode, depending on their
cognitive and physical state. They were interviewed again at 6
months. Participants were asked to complete a range of outcome
measures that provided information on functional status and psycho-
logical well-being. The measures of mood included the GHQ-287
and the Present State Examination (PSE).27
The GHQ-28 is a broad measure of psychiatric morbidity that
includes a subscale for severe depression. The GHQ-28 is probably
the most extensively tested scale for reliability, validity, and sensi-
tivity to change across the world.28 Each symptom/question has 4
possible answers: “not at all,” “no more than usual,” “rather more
than usual,” and “much more than usual,” Scores range from 0 (the
best possible) to 28 (the worst possible) on standard scoring
(0,0,1,1).7 We used the recommended threshold of 11 to indicate
caseness in those with comorbid physical illness.29 A negative
cognition or suicidal thought was considered endorsed if a response
was other than “not at all” on the GHQ-28 depression subscale.
The PSE consists of standardized questions administered by a
trained interviewer and can yield output consistent with the diagnos-
tic criteria of the DSM3 and ICD.30 It includes question 18, “How
have you felt in your mood in the past month? Do you keep
reasonably cheerful or have you been depressed or low-spirited
recently?” which is equivalent to the Yale question.
Depressive symptoms were assessed in ARCOS and SOS2 in
cognitively competent participants (no proxy data are reported) who
were able to respond for themselves by trained nursing and medical
interviewers. The Auckland ethics committee approved the ARCOS
study; the Leeds Teaching Hospital Trust and the Bradford Hospitals
Trust local research ethics committees approved the SOS2 study, and
written, informed consent was obtained from all participants.
Demographic data from ARCOS and SOS2 cohorts and associa-
tions between negative cognitions and demographic characteristics
were compared by 2 or 2-sample t tests, where appropriate. To
assess the presence of important cognitions in participants who did
not answer the single Yale or PSE depression question positively, we
present GHQ-28 item responses for those who were positive
GHQ-28 cases and those who were not a case on the GHQ-28.
Results
Characteristics of the Study Populations
Complete mood data were available at 6 months from 770
ARCOS and 492 SOS2 participants. The demographic char-
acteristics of the study populations are shown in Table 1.
ARCOS and SOS2 participants were similar in age (6913
years), sex, and marital status. More ARCOS participants
were completely independent in activities of daily living,
whereas more SOS2 participants were dependent on others
for help with activities of daily living and met the criteria for
abnormal mood. These differences probably reflect that fact
that ARCOS recruited a community sample whereas the
majority of SOS2 subjects were recruited in hospital.
Abnormal Mood at 6 Months in the Study Group
Overall, 56 (7%) ARCOS participants and 61 (12%) SOS2
participants met the study criteria for caseness on the
GHQ-28 (score 11). Consequently, GHQ-28 mean scores
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(SD) were significantly lower in ARCOS (3.574) partic-
ipants than in SOS2 participants (4.616; t3.39, P0.001).
One hundred fifty-nine (21%, ARCOS) and 129 (26%, SOS2)
participants responded positively to the single simple ques-
tion (see Table 1). Only 40 (5%, ARCOS) and 50 (10%,
SOS2) participants met the criteria for caseness on the
GHQ-28 and responded positively to the single simple
question (see Table 2).
Table 3 shows the proportion of participants who endorsed
negative cognitions or suicidal thoughts on the GHQ-28 but
did not meet the criteria for caseness on the GHQ-28 (score
11) and answered negatively to the Yale question or
question 18 of the PSE. A significant proportion (up to 28%)
of people who did not meet study criteria for depression on 1
or more measures reported important negative cognitions,
such as hopelessness, worthlessness, or suicidality. Being
older was associated (P0.05) with thoughts of being worth-
less, that life was hopeless or not worth living, or wishing
themselves dead for ARCOS and SOS2 participants. Being
dependent in activities of daily living was associated with
feeling that life was hopeless or not worth living (ARCOS)
and wishing themselves dead and away from it all (ARCOS
and SOS2). Not being married or partnered was associated
with thoughts of being worthless, hopeless, and nerves being
bad (SOS2) or life wasn’t worth living or wishing themselves
dead (ARCOS; data not presented).
Discussion
These 2 independently conducted stroke studies have dem-
onstrated that a significant proportion (up to 28%) of patients
with negative cognitions including suicidal thoughts may be
missed by researchers and clinicians who rely on screening
methods such as a single question or a standardized self-
report measure, alone or in combination, to detect depressive
illness. Symptoms listed in the GHQ-28 depression subscale
are important in their own right, because they are markers of
significant distress, even in those who do not have sufficient
other symptoms to warrant a psychiatric diagnosis.
We suggest that clinicians and patients will benefit from
reviewing responses to individual questions on mood rating
scales together, regardless of whether scores are below a
prespecified cutpoint or whether people screen positive or
negative for depression on a single question. Reviewing
individual item responses may provide the opportunity for
frank but sensitive discussions between clinician and patients
about endorsed negative cognitions, including suicidal
thoughts. This process may also facilitate establishment of a
“watchful waiting” period, as recommended in the National
Institute for Health and Clinical Excellence guidelines31 to
prevent unnecessary treatment of mild symptoms of abnormal
mood that may resolve with no intervention.
A strength of our data is the consistency of the phenome-
non in 2 different studies that used similar screening ques-
tions but different methods of assessment. Both studies made
strenuous efforts to avoid bias in sampling and follow-up, and
Table 1. Study Participant Characteristics at Baseline and
Depression Characteristics at Follow-Up
ARCOS Study
n770
n (%)
SOS2
n492
n (%) 2 P
Female 359 (47) 207 (42) 2.513 NS
Married/partnered 460 (61) 282 (57) 0.728 NS
Functional status
BI score20
(independent)
363 (48) 170 (35) 29.77 0.0001
BI score11 to 19 317 (39) 238 (48)
BI score0 to 10 79 (10) 83 (17)
BI score missing 11 (1) 1 (0)
GHQ-28 case () 56 (7) 61 (12) 9.376 0.01
Yale (ARCOS), PSE
(SOS2) case
159 (21) 129 (26) 5.288 ns
BI indicates Barthel Index score; GHQ-28, 28-item GHQ caseness deter-
mined with standard 0, 0, 1, 1 scoring and a threshold score of 11; PSE,
positive endorsement of question 18 of the PSE; and Yale, positive endorse-
ment of the Yale question.
Table 2. Proportion of Study Participants Meeting Caseness
Criteria as Determined by the GHQ-28 (Score >11), According
to Endorsement of the Yale Question or Question 18 of the PSE
About Depressed Mood
ARCOS Study
n770
SOS2
n492
Yale
n (%)
Yale
n (%)
PSE
n (%)
PSE
n (%)
GHQ-28 40 (5) 16 (2) 50 (10) 11 (2)
GHQ-28 119 (16) 595 (77) 79 (16) 352 (72)
 Indicates meeting criteria for caseness; and , not meeting criteria for
caseness. Other abbreviations are as defined in the footnote to Table 1.
Table 3. Proportion of Study Participants Endorsing Negative
Cognitions or Suicidal Thoughts Who Did Not Meet the Study
Criteria for Caseness on the GHQ-28 (Score >11) and Did Not
Positively Endorse the Yale Question or Question 18 of the PSE
About Depressed Mood
GHQ-28 Depression Subscale Questions
ARCOS Study
n730*
n (%)
SOS2
n442†
n (%)
Negative cognitions
Been thinking of yourself as a worthless
person
177 (24) 122 (28)
Felt that life is entirely hopeless 113 (15) 102 (23)
Found at times you couldn’t do anything
because your nerves were too bad?
60 (8) 62 (14)
Suicidal thoughts
Felt that life isn’t worth living? 89 (12) 74 (17)
Thought of the possibility that you
might do away with yourself?
52 (7) 46 (10)
Found yourself wishing you were
dead and away from it all?
77 (11) 64 (14)
Found that the idea of taking your
own life kept coming into your head?
42 (6) 45 (10)
*Total of 770 participants, minus 40 participants scoring as a case on the
GHQ-28 and the Yale question.
†Total of 492 participants, minus 50 participants scoring as a case on the
GHQ-28 and the Yale question.
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a standardized assessment of mood in participants with stroke
was used (GHQ-287), which is an established measure for
assessing depressive symptoms after stroke,32,33 although this
was interviewer administered in one study (ARCOS) and
self-completed in the other (SOS2). It should also be noted
that these were post hoc analyses. As a result, we have been
unable to reinterview participants to explore further the
meaning of negative cognitions in those who answered
questions about depressed mood negatively.
The likelihood of experiencing depression after stroke is
high,1 and many patients do not seek help for or even
recognize abnormal mood symptoms of clinical concern.34
Screening for depression is therefore desirable, but our
conclusion is that alone it is not likely to be an adequate
substitute for a sensitive exploration of the psychological
impact of severe disease on the survivor. Clinically, a single
question about depression, or a high score on a depression
questionnaire, may be useful and is certainly better than
asking nothing, but it is unlikely to elicit important informa-
tion about certain aspects of the patient’s mental state, such as
a sense of worthlessness or hopelessness or thoughts that life
is not worth living. We need more research to understand the
origins of these cognitions and their impact on outcomes.
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